Variations in Breast Cancer Screening Recommendations
Breast screening is performed in individuals without any signs or symptoms of breast cancer so that disease can be detected as early as possible, with the goal of decreasing the overall treatment needed and reducing morbidity and mortality rates.
Team-Based Case Review: Breast Cancer
As a result of the therapeutic advances and clinical research affecting the management of patients with cancer, clinicians can benefit by comparing their individual skills of diagnosis, treatment, and management of patients with their peers. This peer interaction is an integral part in enhancing clinical decision-making skills that can improve patient care.
Cardiovascular Health After Breast Cancer Treatment

Breast cancer survivors are at increased risk of cardiovascular disease (CVD) and death from cardiovascular complications. Therefore, CVD risk assessment and counseling on CVD risk factor management are recommended for all cancer survivors throughout the survivorship continuum.

Issues with Sexuality and Sexual Function in Patients with Breast Cancer

Addressing sexual health is an essential step during the treatment of breast cancer. Healthcare providers should discuss with patients the potential changes in sexual function and sexuality related to cancer treatment as well as the measures that are available to overcome these challenges.

Advances in the Management of Metastatic Breast Cancer with SABCS Updates

This activity covers the following presentations:

  • Advances in the Management of HR-Positive Metastatic Breast Cancer with SABCS Updates
  • Advances in the Management of HER2-Positive Metastatic Breast Cancer with SABCS Updates
Locoregional Management of Breast Cancer with SABCS Updates

This activity covers the following presentations:

  • Updates to Radiation Therapy for DCIS and Invasive Breast Cancer with SABCS Updates
  • Surgical Management of Invasive Breast Cancer with SABCS Updates
Neoadjuvant/Adjuvant Treatment for Breast Cancer with SABCS Updates

This activity covers the following presentations:

Multigene and Biomarker Testing in Breast Cancer

This activity covers the following presentations:

  • Biomarkers and Gene Panel Testing in Early-Stage Breast Cancer
  • Next-Generation Sequencing Testing in the Metastatic Setting
Archived Monthly Oncology Tumor Boards: Sequencing Therapies for Patients with Metastatic HER2-Negative Breast Cancer
With expanding treatment options, clinicians should understand important criteria used in selecting optimal first- and subsequent-line therapies for individuals with metastatic breast cancer. It is important for clinicians to stay up-to-date with the available treatment options to integrate new evidence-based data into their clinical practice, and being familiar with the toxicity profiles is important to optimize patient outcomes.
NCCN 2024 Breast Cancer Congress with Updates from the 2023 San Antonio Breast Cancer Symposium
This program will provide expert insights on the current recommendations of care for patients with breast cancer and include the latest clinical research updates to assist clinicians in formulating breast cancer management strategies.

Pages

Subscribe to RSS - Breast Cancer